Lew Jennifer, EVP and Chief Financial Officer of Annexon, Inc. ($ANNX), made three open market sales of company stock over the past year, totaling about $73,000. Her most recent sale occurred on March 2, 2026. These transactions rank 9,982nd out of 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions per insider. She reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 5565 | $5.42 | 170,700.0000 | 149,123,701 | 3.16% | 0.00% |
| Feb. 19, 2026 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 149,123,701 | 9999.99% | 0.17% |
| Feb. 19, 2026 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Common Stock | 62500 | $0.00 | 176,265.0000 | 149,123,701 | 54.94% | 0.04% |
| Feb. 18, 2026 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 7851 | $5.11 | 113,765.0000 | 149,123,701 | 6.46% | 0.01% |
| July 14, 2025 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1117 | $2.58 | 121,616.0000 | 137,404,145 | 0.91% | 0.00% |
| June 23, 2025 | Boundless Bio, Inc. | $BOLD | Lew Jennifer | Not found | A | Stock Option (right to buy) | 16000 | $0.00 | 16,000.0000 | 22,300,000 | 9999.99% | 0.07% |
| Feb. 27, 2024 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Common Stock | 44963 | $0.00 | 122,733.0000 | 75,673,081 | 57.82% | 0.06% |
| Feb. 27, 2025 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 272575 | $0.00 | 272,575.0000 | 137,404,145 | 9999.99% | 0.20% |
| Feb. 18, 2025 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 6912 | $2.92 | 77,770.0000 | 137,404,145 | 8.16% | 0.01% |
| Feb. 13, 2025 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1786 | $2.98 | 84,682.0000 | 137,404,145 | 2.07% | 0.00% |
| July 15, 2024 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1104 | $6.03 | 86,468.0000 | 75,673,081 | 1.26% | 0.00% |
| March 27, 2024 | Boundless Bio, Inc. | $BOLD | Lew Jennifer | Not found | A | Stock Option | 13219 | $0.00 | 13,219.0000 | 1,248 | 9999.99% | 100.00% |
| Feb. 20, 2024 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 2593 | $5.53 | 82,058.0000 | 75,673,081 | 3.06% | 0.00% |
| Feb. 16, 2024 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Common Stock | 39000 | $0.00 | 84,651.0000 | 75,673,081 | 85.43% | 0.05% |
| Feb. 16, 2024 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 75,673,081 | 9999.99% | 0.21% |
| Feb. 12, 2024 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1809 | $5.54 | 45,651.0000 | 75,673,081 | 3.81% | 0.00% |
| July 11, 2023 | Annexon, Inc. | $ANNX | Lew Jennifer | EVP & Chief Financial Officer | S | Common Stock | 1057 | $3.84 | 47,460.0000 | 0 | 2.18% | 0.00% |